Syndecan-1 as a prognostic biomarker in COVID-19 patients: a retrospective study of a Japanese cohort

Syndecan-1 as a prognostic biomarker in COVID-19 patients: a retrospective study of a Japanese cohort

Abstract Background The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has had a profound global impact, with millions of confirmed cases and deaths worldwide. While most cases are mild, a subset progresses to severe respiratory...

Full description

Bibliographic Details
Main Authors: Kiyohito Hayashi, Daisuke Koyama, Yoichi Hamazaki, Takamichi Kamiyama, Shingo Yamada, Miki Furukawa, Yoshinori Tanino, Yoko Shibata, Takayuki Ikezoe
Format: Article
Language:English
Published: BMC 2024-06-01
Series:Thrombosis Journal
Subjects:
Syndecan-1
Coronavirus
Coronavirus disease 2019
Online Access:https://doi.org/10.1186/s12959-024-00619-2

Internet

https://doi.org/10.1186/s12959-024-00619-2

Similar Items